GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tyche Industries Ltd (BOM:532384) » Definitions » Debt-to-Asset

Tyche Industries (BOM:532384) Debt-to-Asset : 0.00 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Tyche Industries Debt-to-Asset?

Tyche Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Tyche Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹0.0 Mil. Tyche Industries's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₹1,482.9 Mil. Tyche Industries's debt to asset for the quarter that ended in Sep. 2024 was 0.00.


Tyche Industries Debt-to-Asset Historical Data

The historical data trend for Tyche Industries's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tyche Industries Debt-to-Asset Chart

Tyche Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tyche Industries Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tyche Industries's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Tyche Industries's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tyche Industries's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tyche Industries's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Tyche Industries's Debt-to-Asset falls into.



Tyche Industries Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Tyche Industries's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Tyche Industries's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tyche Industries  (BOM:532384) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Tyche Industries Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Tyche Industries's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Tyche Industries Business Description

Traded in Other Exchanges
N/A
Address
D. No. C-21/A, Road No.9, Film Nagar, Jubilee Hills, Hyderabad, TG, IND, 500 096
Tyche Industries Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing of bulk drug intermediates. Geographically, it derives a majority of its revenue from the Export business. The company is a manufacturer in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to the USA and Europe. Its business areas include API, Intermediates, Chiral Intermediates, Nutraceuticals, and CDMO. It operates in a single segment namely the manufacture of bulk drugs intermediates.

Tyche Industries Headlines

No Headlines